Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome. [electronic resource]
Producer: 20190715Description: 71-75 p. digitalISSN:- 1873-5150
- Adrenocorticotropic Hormone -- administration & dosage
- Child, Preschool
- Female
- Humans
- Immunoglobulins, Intravenous -- administration & dosage
- Immunologic Factors -- administration & dosage
- Immunotherapy -- methods
- Inflammation -- therapy
- Lymphopenia -- therapy
- Male
- Opsoclonus-Myoclonus Syndrome -- therapy
- Proof of Concept Study
- Retrospective Studies
- Rituximab -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.